Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

Area of Science:

• Genomics
• Cancer Biology
• Hematology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous cancer with distinct molecular subtypes.
• Previous studies using genome/exome sequencing and RNA-seq identified recurrent somatic point mutations in DLBCL.

Purpose of the Study:

• To provide a whole-genome-sequencing-based analysis of DLBCL mutational complexity.
• To identify novel genes targeted by somatic mutations and deletions.
• To understand the temporal order of mutation acquisition and intratumoral heterogeneity in DLBCL.

Main Methods:

• Whole-genome sequencing of 40 de novo DLBCL cases and 13 DLBCL cell lines.
• DNA copy number analysis and RNA-sequencing on an extended cohort of 96 cases.
• Analysis of genomic rearrangements, fusion transcripts, and somatic point mutations.

Main Results:

• Identified widespread genomic rearrangements, including chromothripsis and novel fusion transcripts.
• Discovered new gene targets for recurrent somatic point mutations and focal somatic deletions.
• Highlighted recurrent mutations in genes regulating B-cell homing (S1P receptor, GNA13, GNAI2).
• Demonstrated ongoing mutation acquisition and intratumoral clonal heterogeneity in DLBCL.

Conclusions:

• This study deepens the understanding of DLBCL lymphomagenesis.
• Identified mutated pathways may suggest new therapeutic intervention strategies.
• Characterized the genomic landscape of DLBCL, revealing key drivers of the disease.